Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred

NCT03512756 is registered in ClinicalTrials.gov with Tyme, Inc as lead sponsor.

NCT NCT03512756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03512756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer Whose Disease Has Progressed or Recurred
Lead sponsor
Tyme, Inc
Phase
Phase 2/3
Overall status
Terminated
Start date
March 27, 2018
Completion date
December 28, 2021
Enrollment
130 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer